{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T13:03:10Z","timestamp":1772110990734,"version":"3.50.1"},"reference-count":38,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":4131,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[1998,1]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> Desferrioxamine (DFX) is an iron chelation agent widely used in the treatment of transfusional iron overload in patients with thalassaemia major and other severe refractory anaemias. DFX has been shown to induce inhibition of DNA synthesis and apoptosis <jats:italic>in vitro<\/jats:italic>; however, the molecular targets of DFX action are not well known. The c\u2010<jats:italic>myc<\/jats:italic> proto\u2010oncogene is involved in a number of cellular processes including proliferation, differentiation and apoptotic cell death. We have examined the expression of c\u2010<jats:italic>myc<\/jats:italic> in peripheral blood mononuclear cells from 71 patients with homozygous \u03b2\u2010thalassaemia in regular transfusion and iron chelation therapy with DFX, 5 non\u2010transfusion, non\u2010chelation\u2010dependent thalassaemic patients, and 15 healthy volunteers using an APAAP immunocytochemical method. We have found that mononuclear cells from thalassaemic patients receiving DFX express significantly lower levels of c\u2010<jats:italic>myc<\/jats:italic> protein compared to control healthy volunteers or thalassaemics receiving no DFX. <jats:italic>In vitro<\/jats:italic> treatment of HL60 or K562 leukaemic cells with 100 \u03bcl DFX also induced a rapid decrease in c\u2010<jats:italic>myc<\/jats:italic> mRNA and protein levels, followed by apoptosis and inhibition of DNA synthesis. These effects were blocked by simultaneous addition of ferric chloride. Our data suggest that deprivation of cellular iron induces downregulation of c\u2010<jats:italic>myc<\/jats:italic> expression <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> and may influence haemopoietic cell growth and survival.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1998.tb00992.x","type":"journal-article","created":{"date-parts":[[2010,7,18]],"date-time":"2010-07-18T04:23:55Z","timestamp":1279427035000},"page":"21-27","source":"Crossref","is-referenced-by-count":20,"title":["Decreased expression of c\u2010<i>myc<\/i> oncoprotein by peripheral blood mononuclear cells in thalassaemia patients receiving desferrioxamine"],"prefix":"10.1111","volume":"60","author":[{"given":"D.","family":"Kyriakou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. G.","family":"Eliopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Papadakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Alexandrakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. D.","family":"Eliopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1987.tb02513.x"},{"key":"e_1_2_1_3_2","first-page":"773","article-title":"Regulation of cell cycle duration by c\u2010myc levels","volume":"4","author":"Karn J.","year":"1989","journal-title":"Oncogene"},{"key":"e_1_2_1_4_2","first-page":"69","article-title":"C\u2010myc: evidence for multiple regulatory functions","volume":"1","author":"Penn LJZ","year":"1990","journal-title":"Semin Cancer Biol"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.6.12.1521738"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.ge.20.120186.002045"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(92)90123-T"},{"key":"e_1_2_1_8_2","first-page":"2153","article-title":"The effect of doxorubicin, daunorubicin and 4\u2032\u2010epidoxorubicin on the exogenous c\u2010myc promoter in mouse erythroleukemia cells","volume":"11","author":"Eliopoulos AG","year":"1991","journal-title":"Anticancer Res"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(95)00085-E"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.16.5323"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/320760a0"},{"key":"e_1_2_1_12_2","first-page":"883","article-title":"Changes in FOS\/JUN binding activity on a negative regulatory element of c\u2010myc during differentiation of mouse erythroleukemic cells","volume":"2","author":"Eliopoulos AG","year":"1993","journal-title":"Int J Oncol"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/359423a0"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90663-B"},{"key":"e_1_2_1_15_2","first-page":"327","volume-title":"Hematology \u2013 basic principles and practice","author":"Brittenham GM.","year":"1991"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199005020-00005"},{"key":"e_1_2_1_17_2","first-page":"183","article-title":"Desferrioxamine treatment during early pregnancy","volume":"78","author":"Voskaridou E.","year":"1993","journal-title":"Haematologica"},{"key":"e_1_2_1_18_2","first-page":"492","article-title":"Prospects for oral iron chelation therapy","volume":"123","author":"Hoffbrand AV.","year":"1994","journal-title":"J Lab Clin Med"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1976.tb03570.x"},{"key":"e_1_2_1_20_2","first-page":"568","article-title":"Growth inhibition and promotion of differentiation induction in cultured leukemia cell lines by desferrioxamine","volume":"50","author":"Tomoyasu S.","year":"1987","journal-title":"Acta Haematol Jpn"},{"key":"e_1_2_1_21_2","first-page":"176","article-title":"Mechanisms of inhibition of mononuclear cell activation by the iron chelating agent desferrioxamine","volume":"71","author":"Polson RJ","year":"1990","journal-title":"Immunology"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(94)00755-1"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb08927.x"},{"key":"e_1_2_1_24_2","first-page":"428","article-title":"Induction of apoptosis by iron deprivation in human leukemic CCRF\u2010CEM cells","volume":"23","author":"Riaz\u2010ul\u2010Hag","year":"1995","journal-title":"Exp Hematol"},{"key":"e_1_2_1_25_2","first-page":"3571","article-title":"Cell cycle specific effects of desferrioxamine on human and murine haemopoetic progenitor cells","volume":"48","author":"Nocka KH","year":"1988","journal-title":"Cancer Res"},{"key":"e_1_2_1_26_2","first-page":"84","volume-title":"Practical Haematology","author":"Dacie JV","year":"1984"},{"key":"e_1_2_1_27_2","first-page":"1","article-title":"Increased expression of c\u2010myc p67 oncoprotein in patients with myelodysplastic syndromes in transformation to acute leukaemia","volume":"28","author":"Kyriakou D.","year":"1996","journal-title":"Haematologia"},{"key":"e_1_2_1_28_2","first-page":"1217","article-title":"The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and bcl\u20102.","volume":"11","author":"Eliopoulos AG","year":"1995","journal-title":"Oncogene"},{"key":"e_1_2_1_29_2","first-page":"153","volume-title":"Methods in cell biology","author":"McGahon AJ","year":"1995"},{"key":"e_1_2_1_30_2","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1182\/blood.V50.3.433.433","article-title":"Low molecular weight intracellular iron compartments","volume":"50","author":"Jacobs A.","year":"1977","journal-title":"Blood"},{"key":"e_1_2_1_31_2","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood.V75.10.1903.1903","article-title":"Manipulations of cellular iron metabolism for normal and malignant cell proliferation: achievments and prospects","volume":"75","author":"Cazzola M.","year":"1990","journal-title":"Blood"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1992.tb03026.x"},{"key":"e_1_2_1_33_2","first-page":"300","article-title":"Membrane expression of human blood monocytes \u2013 regulation by desferrioxamine","volume":"80","author":"Philippe C.","year":"1993","journal-title":"Immunology"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03348942"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.40.263"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1992.tb04587.x"},{"key":"e_1_2_1_37_2","first-page":"191","article-title":"Immunohistochemical pattern in heterozygote beta thalassaemic subjects","volume":"12","author":"Galerani M.","year":"1990","journal-title":"Riv Eur Sci Med Farmacol"},{"key":"e_1_2_1_38_2","first-page":"406","article-title":"Serum levels of cytokins and soluble antigens in polytransfused patients with beta\u2010thalassaemia major: relationship to immune status","volume":"79","author":"Lombardi G.","year":"1994","journal-title":"Haematologica"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-100-2-173"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1998.tb00992.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1998.tb00992.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T00:16:43Z","timestamp":1698452203000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1998.tb00992.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,1]]}},"alternative-id":["10.1111\/j.1600-0609.1998.tb00992.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1998.tb00992.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,1]]}}}